Bridgepoint Group (LON:BPT) Price Target Cut to GBX 395 by Analysts at Citigroup

Bridgepoint Group (LON:BPT) had its price target lowered by Citigroup from GBX 415 to GBX 395 in a research note released on Tuesday,Digital Look reports. Citigroup currently has a buy rating on the stock.

Separately, JPMorgan Chase & Co. raised their price objective on Bridgepoint Group from GBX 395 to GBX 415 and gave the stock a “buy” rating in a research note on Monday, January 5th. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, Bridgepoint Group presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 385.

Bridgepoint Group Stock Performance

Shares of LON:BPT opened at GBX 255.60 on Tuesday. Bridgepoint Group has a 52-week low of GBX 212 and a 52-week high of GBX 366.68. The stock has a market cap of £2.24 billion, a price-to-earnings ratio of 52.16, a PEG ratio of 0.61 and a beta of 1.35. The company has a quick ratio of 3.60, a current ratio of 279.03 and a debt-to-equity ratio of 55.04. The business has a 50-day moving average price of GBX 244.38 and a 200-day moving average price of GBX 273.52.

Bridgepoint Group (LON:BPT) last announced its quarterly earnings data on Thursday, March 12th. The company reported GBX 26.50 earnings per share (EPS) for the quarter. Bridgepoint Group had a return on equity of 4.25% and a net margin of 7.68%. Equities analysts predict that Bridgepoint Group will post 17.4062165 EPS for the current year.

Insiders Place Their Bets

In related news, insider Michelle Scrimgeour purchased 21,616 shares of Bridgepoint Group stock in a transaction that occurred on Thursday, March 12th. The stock was bought at an average cost of GBX 230 per share, for a total transaction of £49,716.80. Corporate insiders own 0.60% of the company’s stock.

Bridgepoint Group Company Profile

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.